Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 4531 to 4545 of 7685 results

  1. Further research on unilateral MRI-guided focused ultrasound thalamotomy for moderate to severe tremor in Parkinson's disease, which could include randomised controlled trials, should address patient selection and report on long-term follow-up.

    Recommendation ID IPG606/1 Question Further research on unilateral MRI-guided focused ultrasound thalamotomy for moderate to severe tremor

    Research recommendation
    Published
    13 November 2018

  2. Further research, preferably in the form of randomised controlled trials, should assess the effect of the procedure on local tumour control, patient survival, paincontrol and quality of life.

    Recommendation ID IPG579/1 Question Further research, preferably in the form of randomised controlled trials, should assess the effect

    Research recommendation
    Published
    12 October 2018

  3. Further research should focus on the extended use of telemetric adjustable pulmonary artery banding for ventricular retraining and for its use pending the resolution of ventricular septal defects. Data collection may provide useful information. NICE may review the procedure on publication of further evidence.

    Recommendation ID IPG505/1 Question Further research should focus on the extended use of telemetric adjustable pulmonary artery banding

    Research recommendation
    Published
    9 June 2015

  4. Further research should include clear documentation of patient selection and of all complications. Outcomes should include pregnancy rates, live birth rates and instances of preterm delivery. Comparative studies would be helpful. NICE may update the guidance on publication of further evidence.

    Recommendation ID IPG509/1 Question Further research should include clear documentation of patient selection and of all complications.

    Research recommendation
    Published
    9 June 2015

  5. Further research should include details of patient selection and report longer term outcomes.

    Recommendation ID IPG777 Question Further research should include details of patient selection and report longer term outcomes. Any

    Research recommendation
    Published
    11 January 2024

  6. Further research should include details of patient selection, durability and the incidence of complications. Outcomes should be published.

    Recommendation ID IPG642/1 Question Further research should include details of patient selection, durability and the incidence of complications

    Research recommendation
    Published
    19 March 2019

  7. Further research should report:

    Recommendation ID IPG773 Question Further research should report: Any explanatory notes(if applicable) details of patient

    Research recommendation
    Published
    11 January 2024

  8. Further research should report details of patient selection, duration of the effect (including whether repeat procedures are needed), and long term outcomes.

    Recommendation ID IPG771 Question Further research should report details of patient selection, duration of the effect (including whether

    Research recommendation
    Published
    11 January 2024

  9. Further research should report details of patient selection, nodule size and position, and whether the nodule is cystic.

    Recommendation ID IPG643/1 Question Further research should report details of patient selection, nodule size and position, and whether

    Research recommendation
    Published
    19 March 2019

  10. Further studies on the clinical effectiveness of mifamurtide when combined with the chemotherapy typical of UK clinical practice would be useful to determine the size of the effect of mifamurtide.

    Recommendation ID TA235/1 Question Further studies on the clinical effectiveness of mifamurtide when combined with the chemotherapy typical

    Research recommendation
    Published
    9 June 2015

  11. Further research studies into deep brain stimulation (DBS) for intractable trigeminal autonomic cephalalgias (TACs) should clearly define patient selection and report the intensity and duration of stimulation, medication use and quality of life, in addition to documenting the effects on headache symptoms as clearly as possible.

    Recommendation ID IPG381/1 Question Further research studies into deep brain stimulation (DBS) for intractable trigeminal autonomic cephalalgias

    Research recommendation
    Published
    9 June 2015

  12. Further evidence to address the uncertainties in the current clinical evidence,including the impact of gammaCore on all treatments and care as well as itslong-term benefits, would be welcome.

    Recommendation ID MTG46/1 Question Further evidence to address the uncertainties in the current clinical evidence,including the impact

    Research recommendation
    Published
    10 February 2020

  13. Further research is recommended on alternative postpartum testing strategies that do not include cord blood typing of all babies born to rhesus-D (D) negative women.

    Recommendation ID DG25/1 Question Further research is recommended on alternative postpartum testing strategies that do not include cord

    Research recommendation
    Published
    10 February 2017

  14. Further research is recommended on clinical outcomes associated with using the ELISA kits (LISA-TRACKER, IDKmonitor and Promonitor) in people whose Crohn's disease is losing response to a TNF-alpha inhibitor. This could be through a prospective study, for local audit, or for submission to a registry. (The IBD Registry is being adapted to receive data on TNF-alpha inhibitor levels and antibodies against TNF-alpha inhibitors).

    Recommendation ID DG22/2 Question Further research is recommended on clinical outcomes associated with using the ELISA kits (LISA-TRACKER

    Research recommendation
    Published
    21 March 2016

  15. Further research is recommended on clinical outcomes associated with using the ELISA kits (LISA-TRACKER, IDKmonitor and Promonitor) to monitor TNF-alpha-inhibitor levels and antibodies to a TNF-alpha inhibitor in people with Crohn's disease whose disease responds to treatment with TNF-alpha inhibitors. This should be evaluated using prospective studies.

    Recommendation ID DG22/3 Question Further research is recommended on clinical outcomes associated with using the ELISA kits (LISA-TRACKER

    Research recommendation
    Published
    21 March 2016